These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 26287512

  • 1. Synthesis of Tolmetin Hydrazide-Hydrazones and Discovery of a Potent Apoptosis Inducer in Colon Cancer Cells.
    Küçükgüzel ŞG, Koç D, Çıkla-Süzgün P, Özsavcı D, Bingöl-Özakpınar Ö, Mega-Tiber P, Orun O, Erzincan P, Sağ-Erdem S, Şahin F.
    Arch Pharm (Weinheim); 2015 Oct; 348(10):730-42. PubMed ID: 26287512
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, cytotoxicity, and pro-apoptosis activity of etodolac hydrazide derivatives as anticancer agents.
    Çıkla P, Özsavcı D, Bingöl-Özakpınar Ö, Şener A, Çevik Ö, Özbaş-Turan S, Akbuğa J, Şahin F, Küçükgüzel ŞG.
    Arch Pharm (Weinheim); 2013 May; 346(5):367-79. PubMed ID: 23609809
    [Abstract] [Full Text] [Related]

  • 3. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
    Kassab AE, Hassan RA.
    Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
    [Abstract] [Full Text] [Related]

  • 4. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents.
    Ibrahim HS, Abou-Seri SM, Ismail NSM, Elaasser MM, Aly MH, Abdel-Aziz HA.
    Eur J Med Chem; 2016 Jan 27; 108():415-422. PubMed ID: 26706352
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of novel (S)-Naproxen hydrazide-hydrazones as potent VEGFR-2 inhibitors and their evaluation in vitro/in vivo breast cancer models.
    Han Mİ, Atalay P, Tunç CÜ, Ünal G, Dayan S, Aydın Ö, Küçükgüzel ŞG.
    Bioorg Med Chem; 2021 May 01; 37():116097. PubMed ID: 33743356
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors.
    Şenkardeş S, Han Mİ, Kulabaş N, Abbak M, Çevik Ö, Küçükgüzel İ, Küçükgüzel ŞG.
    Mol Divers; 2020 Aug 01; 24(3):673-689. PubMed ID: 31302853
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis, anticancer evaluation, and molecular modelling studies of novel tolmetin derivatives as potential VEGFR-2 inhibitors and apoptosis inducers.
    Kassab AE, Gedawy EM, Hamed MIA, Doghish AS, Hassan RA.
    J Enzyme Inhib Med Chem; 2021 Dec 01; 36(1):922-939. PubMed ID: 33896327
    [Abstract] [Full Text] [Related]

  • 13. Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl)hydrazide-hydrazone derivatives.
    Sreenivasulu R, Reddy KT, Sujitha P, Kumar CG, Raju RR.
    Bioorg Med Chem; 2019 Mar 15; 27(6):1043-1055. PubMed ID: 30773423
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and in vitro antitumor activity of novel N-substituted-4-phenyl/benzylphthalazin-1-ones.
    Eldehna WM, Ibrahim HS, Abdel-Aziz HA, Farrag NN, Youssef MM.
    Eur J Med Chem; 2015 Jan 07; 89():549-60. PubMed ID: 25462265
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of novel diflunisal hydrazide-hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors.
    Şenkardeş S, Kaushik-Basu N, Durmaz İ, Manvar D, Basu A, Atalay R, Küçükgüzel ŞG.
    Eur J Med Chem; 2016 Jan 27; 108():301-308. PubMed ID: 26695731
    [Abstract] [Full Text] [Related]

  • 16. Molecular Hybrid Design, Synthesis, In Vitro Cytotoxicity, In Silico ADME and Molecular Docking Studies of New Benzoate Ester-Linked Arylsulfonyl Hydrazones.
    Ergan E, Çakmak R, Başaran E, Mali SN, Akkoc S, Annadurai S.
    Molecules; 2024 Jul 25; 29(15):. PubMed ID: 39124882
    [Abstract] [Full Text] [Related]

  • 17. Effect of methanolic extract from silkworm droppings on proliferation and caspase activity in HT-29 human colon cancer cells.
    Hwang JH, Kim JY, Cha MR, Park HR.
    J Med Food; 2007 Sep 25; 10(3):467-72. PubMed ID: 17887940
    [Abstract] [Full Text] [Related]

  • 18. Synthesis, molecular modeling, in vivo study, and anticancer activity of 1,2,4-triazole containing hydrazide-hydrazones derived from (S)-naproxen.
    Han MI, Bekçi H, Uba AI, Yıldırım Y, Karasulu E, Cumaoğlu A, Karasulu HY, Yelekçi K, Yılmaz Ö, Küçükgüzel ŞG.
    Arch Pharm (Weinheim); 2019 Jun 25; 352(6):e1800365. PubMed ID: 31115928
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Design, synthesis, biological evaluation and molecular modeling of dihydropyrazole sulfonamide derivatives as potential COX-1/COX-2 inhibitors.
    Chen Z, Wang ZC, Yan XQ, Wang PF, Lu XY, Chen LW, Zhu HL, Zhang HW.
    Bioorg Med Chem Lett; 2015 May 01; 25(9):1947-51. PubMed ID: 25866240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.